Landers, Constantin
Ormond, Kelly E.
Blasimme, Alessandro
Brall, Caroline
Vayena, Effy
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NRP 77, #407740_187356 / 1)
Swiss Personalized Health Network (1-002552 Support for ELSI)
Swiss Federal Institute of Technology Zurich
Article History
Received: 29 July 2022
Accepted: 25 April 2023
First Online: 18 May 2023
Declarations
:
: Effy Vayena and Alessandro Blasimme received an expert fee from Roche in 2020. Effy Vayena is a member in IQVIA’s ethics advisory panel and in Merck KGaA’s Digital Ethics Advisory Panel. Constantin Landers, Kelly Ormond, and Caroline Brall have no financial interests to declare.
: No ethics approval/consent was required for this research.